Comparative Pharmacology
Head-to-head clinical analysis: CLENZ LYTE versus SORBITOL 3 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLENZ LYTE versus SORBITOL 3 IN PLASTIC CONTAINER.
CLENZ-LYTE vs SORBITOL 3% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Colon lavage solution that osmotically induces diarrhea to cleanse the colon.
Sorbitol is a sugar alcohol that acts as an osmotic diuretic. When administered intravenously, it increases plasma osmolality, drawing water from extravascular spaces into the intravascular compartment, thereby reducing intracranial pressure and cerebral edema. It is also used as a hyperosmotic laxative via oral administration, drawing water into the colon to stimulate bowel movements.
Oral: 4 L (or 240 mL every 10 minutes) administered the evening before colonoscopy; alternatively, 2 L (or 240 mL every 10 minutes) plus 2 L of clear liquids given in split doses (first 1-2 L evening before, remaining in morning of procedure).
30 mL of 3% solution (0.9 g) administered intravenously over 30-60 minutes, typically as a single dose.
None Documented
None Documented
Not applicable; systemic absorption is negligible (plasma levels below detection limits). Clinical effect is localized to gastrointestinal tract.
Terminal elimination half-life is approximately 1.5-2 hours in patients with normal renal function; prolonged in renal impairment (up to 6 hours in anuria).
Primarily fecal (approximately 95%) as unabsorbed polyethylene glycol; negligible renal excretion (<5%) as intact polymer.
Sorbitol is primarily excreted renally as metabolites (fructose and glucose) and unchanged drug; approximately 50-70% is recovered in urine over 24 hours, with less than 10% eliminated in feces.
Category C
Category C
Laxative
Laxative